XML 29 R16.htm IDEA: XBRL DOCUMENT
v3.25.1

LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS | 3 Months Ended
--- | ---
Mar. 31, 2025
Insurance [Abstract] |
LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS | DAC AND OTHER DEFERRED ASSETS/LIABILITIES The following table presents a reconciliation of DAC to the consolidated balance sheets:
| March 31 |  | December 31 |  |
| 2025 |  | 2024 |  |
| (in millions)
Protection Solutions |  |  |  |  |
Term | $ | 307 |  |  | $ | 314 |  |  |
Universal Life | 172 |  |  | 170 |  |  |
Variable Universal Life | 1,102 |  |  | 1,083 |  |  |
Indexed Universal Life | 186 |  |  | 186 |  |  |
Individual Retirement |  |  |  |  |
GMxB Core | 1,604 |  |  | 1,605 |  |  |
EQUI-VEST Individual | 154 |  |  | 154 |  |  |
Investment Edge | 236 |  |  | 225 |  |  |
SCS | 2,018 |  |  | 1,938 |  |  |
Legacy Segment |  |  |  |  |
GMxB Legacy | 504 |  |  | 517 |  |  |
Group Retirement |  |  |  |  |
EQUI-VEST Group | 771 |  |  | 768 |  |  |
Momentum | 82 |  |  | 83 |  |  |
Corporate and Other | 105 |  |  | 107 |  |  |
Other | 21 |  |  | 20 |  |  |
Total | $ | 7,262 |  |  | $ | 7,170 |  |  |
Annually, or as circumstances warrant, the Company reviews the associated decrements assumptions (i.e., mortality and lapse) based on our multi-year average of companies experience with actuarial judgements to reflect other observable industry trends. In addition to DAC, the unearned revenue liability and sales inducement asset (“SIA”) use similar techniques and quarterly update processes for balance amortization. Changes in the DAC asset were as follows:
| Three Months Ended March 31, 2025
| Protection Solutions |  | Individual Retirement |  | Legacy |  | Group Retirement |  | Corporate and Other |  | Total
| Term |  | UL |  | VUL |  | IUL |  | GMxB Core |  | EI |  | IE |  | SCS |  | GMxB Legacy |  | EG |  | Momentum |  | CB (1) |
| (in millions)
Balance, beginning of period | $ | 314 |  |  | $ | 170 |  |  | $ | 1,083 |  |  | $ | 186 |  |  | $ | 1,605 |  |  | $ | 154 |  |  | $ | 225 |  |  | $ | 1,938 |  |  | $ | 517 |  |  | $ | 768 |  |  | $ | 83 |  |  | $ | 107 |  |  | $ | 7,150 |
Capitalization | 2 |  |  | 5 |  |  | 35 |  |  | 3 |  |  | 37 |  |  | 3 |  |  | 16 |  |  | 157 |  |  | 5 |  |  | 15 |  |  | 3 |  |  | — |  |  | 281 |
Amortization (2) | (9) |  |  | (3) |  |  | (16) |  |  | (3) |  |  | (38) |  |  | (3) |  |  | (5) |  |  | (77) |  |  | (18) |  |  | (12) |  |  | (4) |  |  | (2) |  |  | (190) |
Balance, end of period | $ | 307 |  |  | $ | 172 |  |  | $ | 1,102 |  |  | $ | 186 |  |  | $ | 1,604 |  |  | $ | 154 |  |  | $ | 236 |  |  | $ | 2,018 |  |  | $ | 504 |  |  | $ | 771 |  |  | $ | 82 |  |  | $ | 105 |  |  | $ | 7,241 |
______________ (1)“CB” defined as Closed Block. (2)Includes an immaterial impact from Novation. See Note 1 for additional details.
| Three Months Ended March 31, 2024
| Protection Solutions |  | Individual Retirement |  | Legacy |  | Group Retirement |  | Corporate and Other |  | Total
| Term |  | UL |  | VUL |  | IUL |  | GMxB Core |  | EI |  | IE |  | SCS |  | GMxB Legacy |  | EG |  | Momentum |  | CB |
| (in millions)
Balance, beginning of period | $ | 337 |  |  | $ | 174 |  |  | $ | 987 |  |  | $ | 188 |  |  | $ | 1,602 |  |  | $ | 155 |  |  | $ | 172 |  |  | $ | 1,571 |  |  | $ | 555 |  |  | $ | 742 |  |  | $ | 82 |  |  | $ | 116 |  |  | $ | 6,681 |
Capitalization | 4 |  |  | 3 |  |  | 37 |  |  | 2 |  |  | 39 |  |  | 2 |  |  | 12 |  |  | 148 |  |  | 7 |  |  | 15 |  |  | 2 |  |  | — |  |  | 271 |
Amortization (1) | (10) |  |  | (3) |  |  | (15) |  |  | (3) |  |  | (37) |  |  | (3) |  |  | (4) |  |  | (64) |  |  | (16) |  |  | (10) |  |  | (4) |  |  | (2) |  |  | (171) |
Balance, end of period | $ | 331 |  |  | $ | 174 |  |  | $ | 1,009 |  |  | $ | 187 |  |  | $ | 1,604 |  |  | $ | 154 |  |  | $ | 180 |  |  | $ | 1,655 |  |  | $ | 546 |  |  | $ | 747 |  |  | $ | 80 |  |  | $ | 114 |  |  | $ | 6,781 |
______________ (1) DAC amortization of $1 million related to Other not reflected in table above. Changes in the Individual Retirement sales inducement assets were as follows:
| Three Months Ended March 31,
| 2025 |  | 2024 |  |
| GMxB Core |  | GMxB Legacy |  | GMxB Core |  | GMxB Legacy |  |  |  |
| (in millions)
Balance, beginning of period | $ | 117 |  |  | $ | 160 |  |  | $ | 127 |  |  | $ | 179 |  |  |  |  |
Capitalization | — |  |  | — |  |  | 1 |  |  | — |  |  |  |  |
Amortization | (3) |  |  | (5) |  |  | (3) |  |  | (5) |  |  |  |  |
Balance, end of period | $ | 114 |  |  | $ | 155 |  |  | $ | 125 |  |  | $ | 174 |  |  |  |  |
Changes in the Protection Solutions unearned revenue liability were as follows:
| Three Months Ended March 31,
| 2025 |  | 2024 |  |
| UL |  | VUL |  | IUL |  | UL |  | VUL |  | IUL |  |  |  |  |  |
| (in millions)
Balance, beginning of period | $ | 114 |  |  | $ | 840 |  |  | $ | 250 |  |  | $ | 107 |  |  | $ | 754 |  |  | $ | 210 |  |  |  |  |  |  |
Capitalization | 3 |  |  | 37 |  |  | 12 |  |  | 4 |  |  | 32 |  |  | 14 |  |  |  |  |  |  |
Amortization | (2) |  |  | (13) |  |  | (4) |  |  | (2) |  |  | (12) |  |  | (3) |  |  |  |  |  |  |
Balance, end of period | $ | 115 |  |  | $ | 864 |  |  | $ | 258 |  |  | $ | 109 |  |  | $ | 774 |  |  | $ | 221 |  |  |  |  |  |  |
LIABILITIES FOR FUTURE POLICYHOLDER BENEFITS The following table reconciles the net liability for future policy benefits and liability of death benefits to the liability for future policy benefits in the consolidated balance sheets:
| March 31, 2025 |  | December 31, 2024
| (in millions)
Reconciliation |  |  |
Term | $ | 1,292 |  |  | $ | 1,285 |
Payout | 4,782 |  |  | 5,050 |
Group Pension - Benefit Reserve & DPL | 454 |  |  | 460 |
Health | 1,353 |  |  | 1,362 |
UL | 1,264 |  |  | 1,246 |
Subtotal | 9,145 |  |  | 9,403 |
Whole Life Closed Block and Open Block products | 5,142 |  |  | 5,204 |
Other (1) | 908 |  |  | 901 |
Future policyholder benefits total | 15,195 |  |  | 15,508 |
Other policyholder funds and dividends payable | 2,177 |  |  | 2,105 |
Total | $ | 17,372 |  |  | $ | 17,613 |
_____________ (1)Primarily consists of future policy benefits related to Protective Life and Annuity, Assumed Life and Disability, Group Life Run off, Variable Interest Sensitive Life rider and EB. The following table summarizes balances and changes in the liability for future policy benefits for nonparticipating traditional and limited pay contracts:
| Three Months Ended March 31, 2025 |  | Three Months Ended March 31, 2024
| Protection Solutions |  | Individual Retirement |  | Corporate & Other |  | Protection Solutions |  | Individual Retirement |  | Corporate & Other
| Term |  | Payout |  | Group Pension |  | Health |  | Term |  | Payout |  | Group Pension |  | Health
| (in millions)
Present Value of Expected Net Premiums |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, beginning of period | $ | 1,932 |  |  | $ | — |  |  | $ | — |  |  | $ | (25) |  |  | $ | 2,133 |  |  | $ | — |  |  | $ | — |  |  | $ | (21) |
Beginning balance at original discount rate | 1,959 |  |  | — |  |  | — |  |  | (26) |  |  | 2,058 |  |  | — |  |  | — |  |  | (22) |
Effect of changes in cash flow assumptions | — |  |  | — |  |  | — |  |  | — |  |  | (18) |  |  | — |  |  | — |  |  | — |
Effect of actual variances from expected experience | (29) |  |  | — |  |  | — |  |  | (2) |  |  | (18) |  |  | — |  |  | — |  |  | 1 |
Adjusted beginning of period balance | 1,930 |  |  | — |  |  | — |  |  | (28) |  |  | 2,022 |  |  | — |  |  | — |  |  | (21) |
Issuances | 11 |  |  | — |  |  | — |  |  | — |  |  | 11 |  |  | — |  |  | — |  |  | — |
Interest accrual | 24 |  |  | — |  |  | — |  |  | — |  |  | 25 |  |  | — |  |  | — |  |  | — |
Net premiums collected | (46) |  |  | — |  |  | — |  |  | 1 |  |  | (49) |  |  | — |  |  | — |  |  | 1 |
Ending Balance at original discount rate | 1,919 |  |  | — |  |  | — |  |  | (27) |  |  | 2,009 |  |  | — |  |  | — |  |  | (20) |
Effect of changes in discount rate assumptions | (7) |  |  | — |  |  | — |  |  | 1 |  |  | 17 |  |  | — |  |  | — |  |  | 1 |
Balance, end of period | $ | 1,912 |  |  | $ | — |  |  | $ | — |  |  | $ | (26) |  |  | $ | 2,026 |  |  | $ | — |  |  | $ | — |  |  | $ | (19) |
Present Value of Expected Future Policy Benefits |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, beginning of period | $ | 3,216 |  |  | $ | 5,050 |  |  | $ | 460 |  |  | $ | 1,337 |  |  | $ | 3,480 |  |  | $ | 4,464 |  |  | $ | 490 |  |  | $ | 1,484 |
Beginning balance of original discount rate | 3,215 |  |  | 5,390 |  |  | 514 |  |  | 1,555 |  |  | 3,330 |  |  | 4,680 |  |  | 536 |  |  | 1,672 |
Effect of changes in cash flow assumptions (1) | — |  |  | (468) |  |  | — |  |  | — |  |  | (20) |  |  | — |  |  | — |  |  | — |
Effect of actual variances from expected experience | (39) |  |  | (1) |  |  | — |  |  | (6) |  |  | (23) |  |  | (3) |  |  | 1 |  |  | 1 |
Adjusted beginning of period balance | 3,176 |  |  | 4,921 |  |  | 514 |  |  | 1,549 |  |  | 3,287 |  |  | 4,677 |  |  | 537 |  |  | 1,673 |
Issuances | 11 |  |  | 201 |  |  | — |  |  | — |  |  | 12 |  |  | 279 |  |  | — |  |  | — |
Interest accrual | 40 |  |  | 51 |  |  | 5 |  |  | 13 |  |  | 41 |  |  | 45 |  |  | 5 |  |  | 14 |
Benefits payments | (58) |  |  | (127) |  |  | (16) |  |  | (38) |  |  | (64) |  |  | (113) |  |  | (16) |  |  | (41) |
Ending Balance at original discount rate | 3,169 |  |  | 5,046 |  |  | 503 |  |  | 1,524 |  |  | 3,276 |  |  | 4,888 |  |  | 526 |  |  | 1,646 |
Effect of changes in discount rate assumptions | 34 |  |  | (264) |  |  | (49) |  |  | (197) |  |  | 65 |  |  | (302) |  |  | (53) |  |  | (215) |
Balance, end of period | $ | 3,203 |  |  | $ | 4,782 |  |  | $ | 454 |  |  | $ | 1,327 |  |  | $ | 3,341 |  |  | $ | 4,586 |  |  | $ | 473 |  |  | $ | 1,431 |
Impact of flooring LFPB at zero | 1 |  |  | — |  |  | — |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | — |
Net liability for future policy benefits | $ | 1,292 |  |  | 4,782 |  |  | 454 |  |  | 1,353 |  |  | 1,316 |  |  | 4,586 |  |  | 473 |  |  | 1,450 |
Less: Reinsurance recoverable | 6 |  |  | (960) |  |  | — |  |  | (1,060) |  |  | 24 |  |  | (1,069) |  |  | — |  |  | (1,147) |
Net liability for future policy benefits, after reinsurance recoverable | $ | 1,298 |  |  | $ | 3,822 |  |  | $ | 454 |  |  | $ | 293 |  |  | $ | 1,340 |  |  | $ | 3,517 |  |  | $ | 473 |  |  | $ | 303 |
Weighted-average duration of liability for future policyholder benefits (years) | 6.8 |  | 7.7 |  | 6.9 |  | 8.3 |  | 6.9 |  | 8.0 |  | 7.0 |  | 8.6
______________ (1)For the first quarter 2025, this is the net income impact due to novation as described in Note 1. The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses related to nonparticipating traditional and limited payment contracts:
| March 31, 2025 |  | December 31, 2024 |  |
| (in millions) |  |
Term |  |  |  |  |
Expected future benefit payments and expenses (undiscounted) | $ | 5,530 |  |  | $ | 5,613 |  |  |
Expected future gross premiums (undiscounted) | 6,511 |  |  | 6,597 |  |  |
Expected future benefit payments and expenses (discounted; AOCI basis) | 3,203 |  |  | 3,216 |  |  |
Expected future gross premiums (discounted; AOCI basis) | 3,503 |  |  | 3,507 |  |  |
Payout |  |  |  |  |
Expected future benefit payments and expenses (undiscounted) | 7,166 |  |  | 7,686 |  |  |
Expected future gross premiums (undiscounted) | — |  |  | — |  |  |
Expected future benefit payments and expenses (discounted; AOCI basis) | 4,662 |  |  | 4,938 |  |  |
Expected future gross premiums (discounted; AOCI basis) | — |  |  | — |  |  |
Group Pension |  |  |  |  |
Expected future benefit payments and expenses (undiscounted) | 616 |  |  | 630 |  |  |
Expected future gross premiums (undiscounted) | — |  |  | — |  |  |
Expected future benefit payments and expenses (discounted; AOCI basis) | 432 |  |  | 436 |  |  |
Expected future gross premiums (discounted; AOCI basis) | — |  |  | — |  |  |
Health |  |  |  |  |
Expected future benefit payments and expenses (undiscounted) | 2,093 |  |  | 2,139 |  |  |
Expected future gross premiums (undiscounted) | 67 |  |  | 70 |  |  |
Expected future benefit payments and expenses (discounted; AOCI basis) | 1,313 |  |  | 1,323 |  |  |
Expected future gross premiums (discounted; AOCI basis) | $ | 53 |  |  | $ | 55 |  |  |
The table below summarizes the revenue and interest related to nonparticipating traditional and limited payment contracts:
| Three Months Ended March 31,
| 2025 |  | 2024 |  |  |  | 2025 |  | 2024 |  |
| Gross Premium |  | Interest Accretion
| (in millions)
Revenue and Interest Accretion |  |  |  |  |  |  |  |  |  |  |
Term | $ | 83 |  |  | $ | 88 |  |  |  |  | $ | 16 |  |  | $ | 16 |  |  |
Payout | 67 |  |  | 68 |  |  |  |  | 53 |  |  | 49 |  |  |
Group Pension | — |  |  | — |  |  |  |  | 5 |  |  | 5 |  |  |
Health | 2 |  |  | 3 |  |  |  |  | 13 |  |  | 14 |  |  |
Total | $ | 152 |  |  | $ | 159 |  |  |  |  | $ | 87 |  |  | $ | 84 |  |  |
The following table provides the weighted average interest rates for the liability for future policy benefits:
|  |  | March 31, 2025 |  | December 31, 2024
Weighted Average Interest Rate |  |  |  |  |
Term |  |  |  |  |
Interest accretion rate |  |  | 5.6 | % |  | 5.6 | %
Current discount rate |  |  | 5.1 | % |  | 5.2 | %
Payout |  |  |  |  |
Interest accretion rate |  |  | 4.4 | % |  | 4.4 | %
Current discount rate |  |  | 5.2 | % |  | 5.3 | %
Group Pension |  |  |  |  |
Interest accretion rate |  |  | 3.4 | % |  | 3.4 | %
Current discount rate |  |  | 5.0 | % |  | 5.2 | %
Health |  |  |  |  |
Interest accretion rate |  |  | 3.4 | % |  | 3.4 | %
Current discount rate |  |  | 5.2 | % |  | 5.4 | %
The following table provides the balance, changes in and the weighted average durations of the additional insurance liabilities:
|  |  | Three Months Ended March 31,
|  |  |  |  | 2025 |  | 2024 |  |
|  |  |  |  | Protection Solutions
|  |  |  |  | UL
|  |  |  |  | (in millions)
Balance, beginning of period |  |  |  |  | $ | 1,246 |  |  | $ | 1,208 |  |  |
Beginning balance before AOCI adjustments |  |  |  |  | 1,302 |  |  | 1,245 |  |  |
Effect of changes in interest rate & cash flow assumptions and model changes |  |  |  |  | — |  |  | — |  |  |
Effect of actual variances from expected experience |  |  |  |  | 5 |  |  | 2 |  |  |
Adjusted beginning of period balance |  |  |  |  | 1,307 |  |  | 1,247 |  |  |
Interest accrual |  |  |  |  | 14 |  |  | 13 |  |  |
Net assessments collected |  |  |  |  | 17 |  |  | 18 |  |  |
Benefit payments |  |  |  |  | (22) |  |  | (21) |  |  |
Ending balance before shadow reserve adjustments |  |  |  |  | 1,316 |  |  | 1,257 |  |  |
Effect of reserve adjustment recorded in AOCI |  |  |  |  | (52) |  |  | (47) |  |  |
Balance, end of period |  |  |  |  | $ | 1,264 |  |  | $ | 1,210 |  |  |
Net liability for additional liability |  |  |  |  | $ | 1,264 |  |  | $ | 1,210 |  |  |
Less: Reinsurance recoverable |  |  |  |  | — |  |  | — |  |  |
Net liability for additional liability, after reinsurance recoverable |  |  |  |  | $ | 1,264 |  |  | $ | 1,210 |  |  |
Weighted-average duration of additional liability - death benefit (years) |  |  |  |  | 19.3 |  | 19.7 |  |
The following tables provide the revenue, interest and weighted average interest rates, related to the additional insurance liabilities:
| Three Months Ended March 31,
| 2025 |  | 2024 |  |  |  | 2025 |  | 2024 |  |
| Assessments |  | Interest Accretion
| (in millions)
Revenue and Interest Accretion |  |  |  |  |  |  |  |  |  |  |
UL | $ | 145 |  |  | $ | 164 |  |  |  |  | $ | 14 |  |  | $ | 14 |  |  |
Total | $ | 145 |  |  | $ | 164 |  |  |  |  | $ | 14 |  |  | $ | 14 |  |  |
|  |  |  |  | Three Months Ended March 31,
|  |  |  |  |  |  | 2025 |  | 2024 |  |
Weighted Average Interest Rate |  |  |  |  |  |  |  |  |  |  |
UL |  |  |  |  |  |  | 4.5 | % |  | 4.5 | % |  |
Interest accretion rate |  |  |  |  |  |  | 4.5 | % |  | 4.5 | % |  |
The discount rate used for additional insurance liabilities reserve is based on the crediting rate at issue.

X
- References No definition available. + Details
Name: | us-gaap_InsuranceAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479838/944-20-50-7 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/944/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 310 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c)(4)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477363/944-310-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 310 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c)(4)(iv) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477363/944-310-50-3 + Details
Name: | us-gaap_InsuranceDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration